Utpal Koppikar is the Chief Financial Officer at Verily, where he's responsible for the finance, real estate and workplace services (REWS) and corporate development functions. Previously, Utpal was Executive Vice President and Chief Financial Officer at Atara Biotherapeutics where he oversaw the finance, information technology and investor relations functions. Prior to Atara, Utpal held several senior financial leadership positions at Gilead Sciences, including Vice President of Corporate and Operations Finance, where he was responsible for R&D, corporate, G&A, process development and manufacturing, and strategic sourcing. Before joining Gilead, Utpal served in multiple senior finance roles at Amgen. He began his career at Honeywell Aerospace (formerly AlliedSignal). Utpal holds a BS in Aerospace Engineering from the University of Maryland, an MS in aeronautical and astronautical engineering from Stanford University, and an MBA in finance and marketing from The Anderson School at UCLA.